Table 2.
Univariable analysis (n = 455) |
Multivariable analysis (n = 440) |
||||
---|---|---|---|---|---|
Variables | Median (IQR) | Estimation (95% CI) | P valuea | Estimation (95% CI) | P valueb |
Study arm | |||||
Central testing | 7 (2–13) | 0 (ref) | 0.34 | 0 (ref) | |
POCT | 7 (3–14) | 0.8 (−0.9 to 2.6) | 0.3 (−1.2 to 1.8) | 0.66 | |
Sex | |||||
M | 7 (2–13) | 0 (ref) | 0.59 | 0 (ref) | |
F | 8 (3–15) | 0.5 (−1.2 to 2.2) | 0.9 (−0.6 to 2.4) | 0.24 | |
Age (/10 years) | 0.7 (0.2 to 1.2) | 0.003 | 0.3 (−0.2 to 0.9) | 0.23 | |
Symptom duration before ED visit (days) | 0.1 (−0.1 to 0.3) | 0.22 | |||
CRB65 score | 2.6 (1.5 to 3.7) | <0.001 | 1.2 (0.1 to 2.4) | 0.041 | |
Charlson’s score | 0.5 (0.2 to 0.9) | 0.005 | |||
Antibiotics before ED | 8 (2–18) | 1.6 (−0.9 to 4.1) | 0.21 | ||
Administered antibiotics in ED | 7 (3–14) | 0.9 (−0.8 to 2.6) | 0.31 | ||
Oseltamivir | 6 (1–13) | −0.2 (−3.1 to 2.7) | 0.88 | ||
Medical ward | 9 (5–15) | 0 (ref) | <0.001 | 0 (ref) | |
ICU | 25 (11–30) | 9 (6 to 12.1) | 8.9 (5.8 to −12.1) | <0.001 | |
Transfer | 9 (6–15) | 0.9 (−1.0 to 2.8) | 0.4 (−1.6 to 2.3) | 0.72 | |
ED ward | 1 (1–2) | −8.3 (−10.1 to −6.5) | −8 (−9.8 to −6.1) | <0.001 | |
Isolation | |||||
Single room | 8 (4–15) | 0 (ref) | 0.39 | ||
Double room with blocked bed | 6 (2–13) | −1.2 (−2.9 to 0.5) | |||
Double room | 10 (8–10) | 0.3 (−7.2 to 7.7) |
ED, emergency department; POCT, point-of-care testing.
P value of the Likelihood Ratio Test.
P value of the Wald test.